首頁 › 多發性骨髓瘤 › 密蘇里 › Kansas City
Kansas City, MO 的 多發性骨髓瘤 臨床試驗
10 項針對 多發性骨髓瘤 的研究正在 Kansas City（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma
招募中1 期
- University of Kansas Hospital-Westwood Cancer Center, Westwood · 距離 5 英里
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
招募中4 期
- Kansas University Medical Center, Westwood · 距離 5 英里
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
招募中3 期
- MidAmerica Cancer Care, Kansas City
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
招募中2 期
- The University of Kansas Cancer Center - Westwood, Westwood · 距離 5 英里
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
招募中3 期
- University of Kansas, Westwood · 距離 5 英里
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
招募中3 期
- Kansas City VA Medical Center, Kansas City
- American Oncology Partners, P.A. Dba MidAmerica Cancer Care, Kansas City
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
招募中3 期
- Kansas City Veterans Affairs Medical Center, Kansas City
Integrated Cancer Repository for Cancer Research
招募中觀察性研究歡迎健康志工
- Saint Luke's Cancer Institute, East, Kansas City
- Saint Luke's Cancer Institute, Kansas City
- Saint Luke's Cancer Institute, Kansas City North, Kansas City
- 還有 1 項
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
招募中3 期
- Research Medical Center, Kansas City
Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma
招募中1 期
- University of Kansas Clinical Research Center, Westwood · 距離 5 英里
其他城市的 多發性骨髓瘤 試驗
- New York City, NY60 項研究
- Boston, MA42 項研究
- Atlanta, GA42 項研究
- Houston, TX38 項研究
- Durham, NC37 項研究
- Nashville, TN32 項研究
- Denver, CO27 項研究
- St. Louis, MO24 項研究
- Rochester, MN24 項研究
- Columbus, OH24 項研究
- Baldwin Park, CA23 項研究
- Edison, NJ22 項研究
Kansas City 的其他研究
- 乳癌34 項研究
- 非小細胞肺癌31 項研究
- 心臟衰竭25 項研究
- 癌症（所有類型）21 項研究
- 肺癌19 項研究
- 大腸直腸癌16 項研究
- 轉移性癌症15 項研究
- 急性髓系白血病15 項研究
- 前列腺癌14 項研究
- 卵巢癌11 項研究
- 肥胖症11 項研究
- 第二型糖尿病11 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。